Study of Drug Uptake in Melanoma Tumors
Author Information
Author(s): Graff B A, Kvinnsland Y, Skretting A, Rofstad E K
Primary Institution: The Norwegian Radium Hospital
Hypothesis
What are the mechanisms governing the uptake of macromolecular therapeutic agents in human melanoma xenografts?
Conclusion
The study found significant intratumour heterogeneity in the uptake of macromolecular therapeutic agents, primarily influenced by blood supply and diffusion conditions.
Supporting Evidence
- The study demonstrated time-independent intratumour heterogeneity in 99mTc-HSA uptake.
- Uptake was lowest in the center of the tumors and increased towards the periphery.
- Blood perfusion was found to be a significant factor influencing drug uptake.
Takeaway
This study looked at how well a type of medicine gets into melanoma tumors, finding that some parts of the tumor get more medicine than others.
Methodology
The study used human melanoma xenografts in mice to measure the uptake of technetium-labelled human serum albumin and analyzed the results using a specialized imaging system.
Potential Biases
Potential bias in the interpretation of imaging data and the effects of animal model differences.
Limitations
The study may not fully represent human tumors due to the use of xenografts in mice.
Participant Demographics
Adult female BALB/c-nu/nu mice were used as hosts for the xenografted tumors.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website